SMIRNE, Carlo
 Distribuzione geografica
Continente #
EU - Europa 1.969
NA - Nord America 1.535
AS - Asia 433
AF - Africa 8
SA - Sud America 1
Totale 3.946
Nazione #
US - Stati Uniti d'America 1.522
IE - Irlanda 597
IT - Italia 314
SE - Svezia 302
DE - Germania 272
UA - Ucraina 188
CN - Cina 130
FR - Francia 113
HK - Hong Kong 112
FI - Finlandia 110
SG - Singapore 100
IN - India 54
GB - Regno Unito 25
CZ - Repubblica Ceca 20
VN - Vietnam 17
BE - Belgio 16
CA - Canada 13
IR - Iran 9
KE - Kenya 5
TR - Turchia 4
EG - Egitto 3
PH - Filippine 3
CH - Svizzera 2
RO - Romania 2
RS - Serbia 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CL - Cile 1
ID - Indonesia 1
IL - Israele 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
NL - Olanda 1
Totale 3.946
Città #
Dublin 597
Jacksonville 359
Dearborn 166
Chandler 152
Hong Kong 110
Wilmington 90
Ann Arbor 81
Piemonte 76
Lawrence 71
Princeton 71
Singapore 70
San Mateo 58
Beijing 49
Andover 41
Ashburn 34
Milan 33
Novara 31
Munich 21
Brno 20
Nanjing 17
Turin 17
Brussels 16
Dong Ket 16
Boardman 15
Helsinki 14
Woodbridge 13
Hefei 12
Norwalk 11
Houston 10
Düsseldorf 9
Philadelphia 9
Bremen 8
Santa Clara 8
Grafing 7
Los Angeles 7
Strasbourg 7
Berlin 6
Fairfield 6
Frankfurt am Main 6
Jinan 6
Kunming 6
Rome 6
Seattle 6
Monmouth Junction 5
Nairobi 5
Naples 5
Palermo 5
Toronto 5
Vercelli 5
Alessandria 4
Augusta 4
Fuzhou 4
Guangzhou 4
West Jordan 4
Brescia 3
Kocaeli 3
Paris 3
Pioltello 3
Redwood City 3
Shenyang 3
Torino 3
Wuhan 3
Appiano Gentile 2
Bagnoli del Trigno 2
Bucharest 2
Bulandshahr 2
Busalla 2
Cairo 2
Caloocan City 2
Casaleggio Novara 2
Cassano Magnago 2
Espoo 2
Ghemme 2
Giugliano In Campania 2
Guanzate 2
Hebei 2
Leawood 2
London 2
Lucca 2
Nanning 2
Ningbo 2
Quzhou 2
Romainville 2
Saint-Fons 2
San Diego 2
Senago 2
Shanghai 2
Zanjan 2
Ardabil 1
Bangalore 1
Baotou 1
Cambridge 1
Casavatore 1
Castelli Calepio 1
Cento 1
Central 1
Central District 1
Concepción 1
Falconara Marittima 1
Filottrano 1
Totale 2.506
Nome #
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 145
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 104
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 95
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 94
The surgical treatment of lung metastases. The prognostic factors and the indications for the surgical approach 83
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 83
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 80
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 77
Gas6/TAM Signaling Components as Novel Biomarkers of Liver Fibrosis 77
Interferon alpha concentrations in blood and peritoneal fluid during treatment for hepatitis C 75
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 69
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 69
Diagnostic value of FibroTest with normal serum aminotransferases 68
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 68
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 67
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 66
Differential expression of transforming growth factors-beta1, -beta2 and -beta3 in human colon carcinoma 65
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma 62
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 61
Influence of angiotensin-converting enzyme I/D gene polymorphism on clinical and histological correlates of chronic hepatitis C 61
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 60
IL28B Polymorphism, Blood Interferon-alpha Concentration, and Disease Stage of HCV Mono-infected and HCV-HIV Co-infected Patients. 60
Fibrosis Progression in HCV Carriers with Mild Hepatitis Who Possess the High-Repetition Variant of the DRD4 Gene, a Genetic Marker for Binge-Drinking and Risk-Seeking Behavior: A Longitudinal Study. 60
Plasma microvesicles in patients admitted to the emergency department for mild traumatic brain injury: First clues to understand their role 60
Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: the role of the AST to platelet ratio index 59
Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C 59
APOLIPOPROTEIN E GENOTYPES MODULATE FIBROSIS PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND PERSISTENTLY NORMAL TRANSAMINASES 59
Vascular endothelial growth factor. From basic research to clinical application 57
ACE genotype, body weight changes and target organ damage in renal transplant recipients 57
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 56
Periostin Circulating Levels and Genetic Variants in Patients with Non-Alcoholic Fatty Liver Disease 56
Acquired post partum hemophilia 55
Antagonistic interactions between gemcitabine and 5-fluorouracil in the human pancreatic carcinoma cell line Capan-2 55
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted by pancreatic carcinoma cells 52
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 52
Sexually transmitted diseases and pelvic inflammatory disease 50
Role of Gas6 and TAM Receptors in the Identification of Cardiopulmonary Involvement in Systemic Sclerosis and Scleroderma Spectrum Disorders 50
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival 49
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 48
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 48
Hepatic arterial infusion chemotherapy for Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 48
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E epsilon4 carriers: relationship with the blood lipid profile 47
Unsuspected strongyloidiasis in hospitalized elderly patients with and without eosinophilia 47
High serum levels of Transforming Growth Factor-beta1, Interleukin-10 and Vascular Endothelial Growth Factor in pancreatic adenocarcinoma patients 45
Imatinib mesylate for the treatment of solid tumours: Recent trials and future directions 45
Chlamydia trachomatis prevalence in North-West Italy 44
Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C 44
KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes 43
Unusual presentation of fatal disseminated varicella zoster virus infection in a patient with lupus nephritis: A case report 43
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 42
Liver biopsy and noninvasive alternatives in relationship to the duration of antiviral treatment for hepatitis C 42
Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma 42
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 42
Human pancreatic carcinoma cells secrete bioactive interleukin-18 after treatment with 5-fluorouracil: implications for anti-tumor immune response 42
Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients 41
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. 41
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases 41
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application 41
The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects 40
Imatinib mesilate: New perspectives in the treatment of solid tumours 40
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 40
The pro-apoptotic factors Fas Ligand and Trail. Molecular mechanisms, physiopathological role and therapeutic potential 39
Imatinib mesylate: new perspectives in the treatment of solid tumours 39
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 39
Exposure to Plasma From Non-alcoholic Fatty Liver Disease Patients Affects Hepatocyte Viability, Generates Mitochondrial Dysfunction, and Modulates Pathways Involved in Fat Accumulation and Inflammation 38
Weight gain after liver transplantation and the I/D polymorphism of the angiotensin-converting enzyme gene 38
Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. 37
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 36
Use, misuse and abuse of diuretics 36
Sofosbuvir-based therapies in genotype 2 hepatitis C virus cirrhosis: A real-life experience with focus on ribavirin dose 36
Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: a multicentre independent study supported by the Italian Drug Agency. 35
T-cell mediated responses against alpha-foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients’ survival 26
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 21
A novel likely pathogenetic variant p.(Cys235Arg) of the MEN1 gene in multiple endocrine neoplasia type 1 with multifocal glucagonomas. 16
Unveiling the Mystery of Adult-Onset Still’s Disease: A Compelling Case Report 14
Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis 11
Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection 6
Totale 4.038
Categoria #
all - tutte 23.728
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.728


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020539 0 0 0 0 0 114 141 49 82 76 69 8
2020/2021499 62 0 63 3 79 26 72 4 73 20 72 25
2021/2022570 12 22 93 58 35 15 64 19 48 28 67 109
2022/20231.263 141 55 67 33 65 130 27 71 611 6 43 14
2023/2024487 35 54 35 15 87 8 91 17 14 11 42 78
2024/2025140 25 7 44 20 26 18 0 0 0 0 0 0
Totale 4.038